11 hasil untuk "PERLEPE, GARYFALLIA"
Menampilkan 1–11 · 0,36 detik · RSS
-
Artikel Jurnal Teks lengkap
Longitudinal urinary LAM measurements in pulmonary tuberculosis patients: preliminary observations
BACKGROUND: Monitoring treatment response in pulmonary tuberculosis (TB) is critical, but non-invasive biomarkers are limited for patients unable to produce sputum. OBJECTIVE: To evaluate the utility of the PATHFAST TB LAM Ag assay in urine for diagnosis and treatment monitoring of pulmonary TB…
-
Artikel Jurnal Teks lengkap
A 44-Year-Old Man With a Solitary, Slowly Enlarging Mediastinal Lesion
A 44-year-old man, who does not smoke, presented for investigation of a right mediastinum lesion as revealed on a routine radiograph that was performed as a requirement of his life insurance. The patient reported no associated symptoms. He did not report shortness of breath, cough, sputum, fever…
-
Artikel Jurnal Teks lengkap
Temporal Associations of the SARS-CoV-2 NP Antigen and Anti-Spike Total Ig Levels with Laboratory Parameters in a Greek Cohort of Hospitalized COVID-19 Patients
BACKGROUND: The direct effect of SARS-CoV-2 on the lungs results in increased hospitalization rates of patients with pneumonia. Severe COVID-19 patients often develop ARDS which is associated with poor prognosis. Assessing risk factors for COVID-19 severity is indispensable for implementing and…
-
Artikel Jurnal Teks lengkap
Alanine aminotransferase serum levels in COVID-19 patients inversely correlate with SARS-CoV-2 antigen
-
Artikel Jurnal Teks lengkap
Understanding COVID-19 Epidemiology and Implications for Control: The Experience from a Greek Semi-Closed Community
Background: We aimed to estimate the SARS-CoV-2 antigen and antibody seroprevalence in one of the worst-affected by the pandemic semi-closed communities in Greece, Deskati, and evaluate the sociodemographic and clinical correlations of functional antibody responses. Methods: The Ag2019n-CoV…
-
Artikel Jurnal Teks lengkap
Proportions and Seasonal Patterns of Respiratory Viruses via Rapid Tests in Adults at a Greek Hospital (Oct. 2023–Mar. 2024)
Background: Respiratory infections pose a major public health threat. The predominant viruses causing viral respiratory infections are influenza A and B (Flu-A, Flu-B), coronaviruses, respiratory syncytial virus (RSV), and adenovirus. This study aims to investigate the proportion of these cases via…
-
Artikel Jurnal Teks lengkap
ExoProK: A Practical Method for the Isolation of Small Extracellular Vesicles from Pleural Effusions
Extracellular vesicles (EVs) are cell-secreted, lipid membrane-enclosed nanoparticles without functional nucleus. EV is a general term that includes various subtypes of particles named microvesicles, microparticles, ectosomes or exosomes. EVs transfer RNA, DNA and protein cargo between proximal and…
-
Artikel Jurnal Teks lengkap
Clinical features and outcomes of viral respiratory infections in adults during the 2023–2024 winter season
The role and impact of viral infections remain a subject of interest, yet comparative data on influenza A/B, RSV, and SARS-CoV-2 in both hospitalized and non-hospitalized patients are limited. In this observational study, we analyzed data from adult patients with respiratory infections who…
-
Artikel Jurnal Teks lengkap
Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?
Background/Aim: The relationship between the kinetics of antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the severity of Coronavirus Disease 2019 (COVID-19) is poorly understood. The aim of the present study was to investigate whether serum SARS-CoV-2 antibody…
-
Artikel Jurnal Teks lengkap
Evaluation of Antibody Kinetics Following COVID-19 Vaccination in Greek SARS-CoV-2 Infected and Naïve Healthcare Workers
We investigated the antibody kinetics after vaccination against COVID-19 in healthcare workers of a Greek tertiary hospital. Eight hundred and three subjects were included, of whom 758 (94.4%) received the BNT162b2 vaccine (Pfizer-BioNTech), eight (1%) mRNA-1273 (Moderna), 14 (1.7%) ChAdOx1…